[HTML][HTML] Treatment of retinoblastoma: what is the latest and what is the future
P Schaiquevich, JH Francis, MB Cancela… - Frontiers in …, 2022 - frontiersin.org
The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …
has changed drastically over the last decade. Landmark developments in local drug …
Treatment of Retinoblastoma: What Is the Latest and What Is the Future
PS Schaiquevich, JH Francis, MB Cancela… - 2022 - ri.conicet.gov.ar
The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …
has changed drastically over the last decade. Landmark developments in local drug …
[引用][C] Treatment of Retinoblastoma: What Is the Latest and What Is the Future
P Schaiquevich, JH Francis, MB Cancela… - Frontiers in Oncology …, 2022 - jglobal.jst.go.jp
Treatment of Retinoblastoma: What Is the Latest and What Is the Future | Article Information |
J-GLOBAL Art J-GLOBAL ID:202202214185685496 Reference number:22A1178764 …
J-GLOBAL Art J-GLOBAL ID:202202214185685496 Reference number:22A1178764 …
Treatment of Retinoblastoma: What Is the Latest and What Is the Future
PS Schaiquevich, JH Francis, MB Cancela… - 2022 - notablesdelaciencia.conicet.gov.ar
The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …
has changed drastically over the last decade. Landmark developments in local drug …
Treatment of Retinoblastoma: What Is the Latest and What Is the Future
PS Schaiquevich, JH Francis, MB Cancela… - 2022 - datosdeinvestigacion.conicet.gov.ar
The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …
has changed drastically over the last decade. Landmark developments in local drug …
[HTML][HTML] Treatment of Retinoblastoma: What Is the Latest and What Is the Future
P Schaiquevich, JH Francis, MB Cancela… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …
has changed drastically over the last decade. Landmark developments in local drug …
Treatment of Retinoblastoma: What Is the Latest and What Is the Future.
P Schaiquevich, JH Francis, MB Cancela… - Frontiers in …, 2022 - europepmc.org
The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …
has changed drastically over the last decade. Landmark developments in local drug …
Treatment of Retinoblastoma: What Is the Latest and What Is the Future
P Schaiquevich, JH Francis… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …
has changed drastically over the last decade. Landmark developments in local drug …